Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: The RESTORE-2 trial

European Journal of Surgical Oncology

Volumn 38, Issue 5, 2012, Pages 382-389

  Perez Cano R ^a   Vranckx, J J ^b   Lasso, J M ^a   Calabrese, C ^c   Merck, B ^d   Milstein, A M ^e   Sassoon, E ^f   Delay, E ^g   Weiler Mithoff, E M ^h  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^e Cytori Therapeutics Inc   (United States)

^f NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^g CENTRE LÉON BÉRARD   (France)

^h GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Autologous E04.936.664 ; Breast C04.588.180.390 ; Carcinoma; Ductal; Mammaplasty E04.680.500 ; Mastectomy; Mesenchymal stem cell transplantation E04.936.225.687.625 ; Segmental E04.466.701 ; Subcutaneous fat A10.165.114.830.750 ; Transplantation

Indexed keywords

ADIPOSE TISSUE; ARTICLE; AUTOLOGOUS ADIPOSE DERIVED REGENERATIVE CELL FAT GRAFTING; CLINICAL TRIAL (TOPIC); FOLLOW UP; HUMAN; OPERATION DURATION; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PATIENT SATISFACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIB; SAFETY; SURGICAL TECHNIQUE; TISSUE TRANSPLANTATION; TREATMENT OUTCOME;

ADIPOCYTES; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; INJECTIONS; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; PROSPECTIVE STUDIES; SUBCUTANEOUS FAT; TREATMENT OUTCOME;

EID: 84859424301     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.02.178     Document Type: Article

References (25)

1. Churgin S, Isakov R, Yetman R. Reconstruction options following breast conservation therapy. Cleve Clin J Med March 2008;75(Suppl. 1):S24-9.
2. Saint-Cyr M, Rojas K, Colohan S, et al. The role of fat Grafting in reconstructive and cosmetic breast surgery: a review of the literature. J Reconstr Microsurg 2011;. [Epub ahead of print].
3. ELFadl D, Garimella V, Mahapatra T, et al. Lipomodelling of the breast: a Review. Breast 2010;19(3):202-9.
4. Zuk P, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7(2):211-28. (Pubitemid 32295155)
5. Matsumoto D, Sato K, Gonda K, et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng 2006;12(12):3375-82. (Pubitemid 46037161)
6. Zhu M, Zhou Z, Chen Y, et al. Supplementation of fat grafts with adipose-derived regenerative cells (ADRCs) improves long-term graft retention. Ann Plast Surg 2009;63(6):222-8.
7. Sterodimas A, de Faria J, Nicaretta B, et al. Autologous fat transplantation versus adipose-derived stem cell-enriched lipografts: a study. Aesthet Surg J 2011;31(6):682-93.
8. Toyoda M, Bukrinksy A, Eguchi M, et al. Autologous fat grafting for breast reconstruction: characterization of graft composition and effects on tumor growth in vivo. Eur J Surg Oncol. Under review.
9. Fraser J, Wulur I, Alfonso Z, Hedrick M. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006; 24(4):150-4.
10. Yoshimura K, Suga H, Eto H. Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation. Regen Med 2009;4(2):265-73.
11. Akita S, Akino K, Hirano A, et al. Mesenchymal stem cell therapy for cutaneous radiation syndrome. Health Phys 2010;98(6):858-62.
12. Tiryaki T, Findikli N, Tiryaki D. Staged stem cell-enriched tissue (SET) injections for soft tissue augmentation in hostile recipient areas: a preliminary report. Aesthetic Plast Surg 2011;35(6):965-71.
13. Lin K, Matsubara Y, Masuda Y, et al. Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 2008;10(4):417-26. (Pubitemid 351983165)
14. Clough K, Cuminet J, Fitoussi A, et al. Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg 1998;41(5):471-81. (Pubitemid 28511788)
15. LENT SOMA Scales for all anatomic sites. Int J Radiat Oncol 1995; 31(5):1049-91.
16. Ware JE. SF-36 Update. Spine 2000;25(24):3130-9.
17. Likert R. A technique for the Measurement of Attitudes. Arch Psychol 1932;. No. 140.
18. Carvajal J, Patino J. Mammographic findings after breast augmentation with autologous fat injection. Aesthet Surg J 2008;28(2): 153-62. (Pubitemid 351434650)
19. Veronesi U, Cascinelli N, Mariani L, et al. Twenty year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347(16): 1227-32. (Pubitemid 35176241)
20. The Cochrane Collaboration. http://www.cochrane.org, [accessed 01.03.11].
21. Delay E, Garson S, Tousson G, Sinna R. Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years. Aesthet Surg J 2009;29(5):360-76.
22. Illouz YG, Sterodimas A. Autologous fat transplantation to the breast: a personal technique with 25 years of experience. Aesthetic Plast Surg 2009;33(5):706-15.
23. Rigotti G, Marchi A, Stringhini P, et al. Determining the oncological risk of autologous lipoaspirate grafting for postmastectomy breast reconstruction. Aesthetic Plast Surg 2010; 34(4):475-80.
24. Petit JY, Lohsiriwat V, Clough KB, et al. The oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: a multicenter study-Milan-Paris-Lyonexperience of 646 lipofilling procedures. Plast Reconstr Surg 2011;128(2):341-6.
25. Petit JY, Botteri E, Lohsiriwat V, et al. Locoregional recurrence risk after lipofilling in breast cancer patients. Ann Oncol 2011.